CareerPlanSign in

Head of Immunodiagnostics and Next Generation Technology

United States - New York - Pearl River💼 Full-time💰 $176,600–$176,600🗓 2026-07-09 → 2026-09-25

Core

Lead next-generation immunodiagnostics strategies and high-throughput ligand binding assay (LBA) development for vaccine clinical trials and epidemiological studies.

Role type

Senior IC Head of Immunodiagnostics and Next Generation Technology

Builds

Novel, automated, high-precision immunodiagnostic assays and robotic sample handling systems

Domain

Biopharmaceuticals / Vaccine R&D / Clinical Immunology

Deliverable

production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work

Required skills

Assay lifecycle management, robotic sample handling, clinical batching, Design of Experiments (DoE), biostatistical analysis, GCLP/cGMP compliance, team leadership, regulatory document authoring

Preferred skills

AI/machine learning for lab automation, algorithmic scheduling, regulatory agency interaction

Technologies

LIMS, DoE software, enterprise suites

Responsibilities

Envision and execute next-generation LBA strategies, manage multiple assay development projects, drive prioritization of clinical epidemiological studies, mentor scientists and subordinate managers, ensure compliance with GCLP/cGMP standards

Seniority

Senior, hands-on IC with management responsibilities

Sourced via workday · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.